Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone therapy and muscle strength after bariatric surgery in hypogonadal men
2018-002365-19Phase 4Active
- Sponsor
- Line Velling Magnussen
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of testosterone in obesity, Hypoandrogenism (TD) and cardiometabolic risk (CMR), sponsored by Line Velling Magnussen. Primary endpoint: Muscle strength. Started Jun 2018; status: active.
02
Drugs
testosterone
03
Conditions
obesityHypoandrogenism (TD)cardiometabolic risk (CMR)
Beyond the preview
Go deeper on 2018-002365-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002365-19.